Polymorphs of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022) were investigated. Two crystalline forms (α- and β-forms) of YM022 were confirmed by powder X- ray diffractometry and differential scanning calorimetry. α- and β-forms were obtained by recrystallization from ethanol and ethanol: water (5: 1), respectively. Amorphous YM022 was obtained by spray drying of YM022 methanol solution. Since both crystalline and amorphous YM022 were sparingly soluble in water, solubilization of YM022 by solid dispersion and wet grinding methods were performed. In vitro dissolution study and in vivo absorption study in dogs were carried out using spray-dried solid dispersion, heat-treated solid dispersion and mechanical mixture. Spray-dried solid dispersion and heat- treated solid dispersion showed enhanced bioavailability, whereas mechanical mixture showed no improvement.
CITATION STYLE
Yano, K., Takamatsu, N., Yamazaki, S., Sako, K., Nagura, S., Tomizawa, S., … Yamamoto, K. (1996). Crystal forms, improvements of dissolution and absorption of poorly water- soluble (R)-1-[2,3-dihydro-1-(2’-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022). Yakugaku Zasshi, 116(8), 639–646. https://doi.org/10.1248/yakushi1947.116.8_639
Mendeley helps you to discover research relevant for your work.